Century Therapeutics Inc.
IPSC | NASDAQ
$1.90
+$0.05 (+2.70%)
Sep 22, 2026, 2:16 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -9.04 | -0.63 | -1.44 | -2.26 | -9.11 | -22.83 |
PEG Ratio | 0.10 | 0.02 | -1.09 | -0.07 | -0.12 | 0.29 |
PS Ratio | 0.79 | 12.06 | 88.11 | 56.99 | n/a | n/a |
PB Ratio | 0.54 | 0.49 | 1.07 | 0.98 | 2.20 | -11.76 |
P/FCF Ratio | -0.82 | -0.72 | -1.93 | -17.90 | -6.51 | -24.50 |
P/OCF Ratio | -0.83 | -0.72 | -2.23 | 21.09 | -9.80 | -30.33 |
OCF/S Ratio | -95.16 | -1.67K | -3.95K | 270.28 | n/a | n/a |
Debt / Equity Ratio | 0.27 | 0.33 | 0.26 | 0.16 | 0.06 | -0.20 |
Quick Ratio | 5.97 | 1.50 | 9.92 | 10.72 | 14.57 | 6.51 |
Current Ratio | 5.97 | 1.50 | 9.92 | 10.72 | 14.57 | 6.51 |
Asset Turnover | 0.49 | 0.02 | 0.01 | 0.01 | n/a | n/a |
Interest Coverage | n/a | n/a | -271.38 | n/a | -74.42 | -129.07 |
Return on Equity | -6.03% | -78.44% | -73.98% | -43.25% | -24.18% | 50.35% |
Return on Assets | -4.28% | -35.83% | -37.89% | -26.91% | -21.91% | -50.18% |
Return on Invested Capital | -7.22% | -60.51% | -42.56% | -28.86% | -22.41% | -51.82% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 88% | 100% | 100% | 100% | n/a | n/a |
Net Profit Margin | -8.78% | -1.92K% | -6.12K% | -2.52K% | n/a | n/a |
Pretax Profit Margin | -8.84% | -1.89K% | -6.03K% | -2.52K% | n/a | n/a |
Operating Profit Margin | -13.78% | -2.1K% | -6.56K% | -2.57K% | n/a | n/a |
FCF Margin | -95.93% | -1.67K% | -4.57K% | -318.37% | n/a | n/a |
EBITDA Margin | 3.16% | -1.69K% | -5.42K% | -2.33K% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove IPSC